Bank of New York Mellon’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $353K | Buy |
67,272
+8,806
| +15% | +$44.4K | ﹤0.01% | 3924 |
|
|
2026
Q1 | $217K | Sell |
58,466
-422
| -0.7% | -$2.91K | ﹤0.01% | 3976 |
|
|
2025
Q4 | $482K | Sell |
58,888
-25,975
| -31% | -$192K | ﹤0.01% | 3632 |
|
|
2025
Q3 | $625K | Buy |
84,863
+1,787
| +2% | +$13.5K | ﹤0.01% | 3471 |
|
|
2025
Q2 | $675K | Sell |
83,076
-587
| -0.7% | -$3.96K | ﹤0.01% | 3343 |
|
|
2025
Q1 | $589K | Buy |
83,663
+3,091
| +4% | +$19.2K | ﹤0.01% | 3365 |
|
|
2024
Q4 | $599K | Buy |
80,572
+33,690
| +72% | +$215K | ﹤0.01% | 3427 |
|
|
2024
Q3 | $231K | Sell |
46,882
-16,894
| -26% | -$88.3K | ﹤0.01% | 3867 |
|
|
2024
Q2 | $327K | Buy |
+63,776
| New | +$378K | ﹤0.01% | 3780 |
|
|
2024
Q1 | – | Sell |
-20,567
| Closed | -$127K | – | 4246 |
|
|
2023
Q4 | $127K | Sell |
20,567
-4,048
| -16% | -$28.1K | ﹤0.01% | 4045 |
|
|
2023
Q3 | $186K | Sell |
24,615
-2,105
| -8% | -$19.2K | ﹤0.01% | 3978 |
|
|
2023
Q2 | $258K | Sell |
26,720
-80,312
| -75% | -$490K | ﹤0.01% | 3892 |
|
|
2023
Q1 | $404K | Buy |
107,032
+5
| +0% | +$28 | ﹤0.01% | 3603 |
|
|
2022
Q4 | $694K | Sell |
107,027
-39
| -0% | -$321 | ﹤0.01% | 3375 |
|
|
2022
Q3 | $952K | Buy |
107,066
+9,992
| +10% | +$102K | ﹤0.01% | 3226 |
|
|
2022
Q2 | $968K | Sell |
97,074
-12,850
| -12% | -$127K | ﹤0.01% | 3231 |
|
|
2022
Q1 | $1.27M | Sell |
109,924
-3,090
| -3% | -$34.4K | ﹤0.01% | 3161 |
|
|
2021
Q4 | $1.25M | Buy |
113,014
+1,346
| +1% | +$13.1K | ﹤0.01% | 3257 |
|
|
2021
Q3 | $1.03M | Sell |
111,668
-127,846
| -53% | -$1.39M | ﹤0.01% | 3376 |
|
|
2021
Q2 | $2.69M | Buy |
239,514
+14,170
| +6% | +$163K | ﹤0.01% | 2812 |
|
|
2021
Q1 | $2.39M | Buy |
225,344
+9,215
| +4% | +$104K | ﹤0.01% | 2830 |
|
|
2020
Q4 | $2.35M | Sell |
216,129
-18,007
| -8% | -$186K | ﹤0.01% | 2754 |
|
|
2020
Q3 | $2.27M | Buy |
234,136
+8,970
| +4% | +$85.4K | ﹤0.01% | 2597 |
|
|
2020
Q2 | $1.79M | Sell |
225,166
-57,852
| -20% | -$597K | ﹤0.01% | 2746 |
|
|
2020
Q1 | $2.46M | Sell |
283,018
-4,718
| -2% | -$49.1K | ﹤0.01% | 2451 |
|
|
2019
Q4 | $3.25M | Sell |
287,736
-8,025
| -3% | -$85.4K | ﹤0.01% | 2558 |
|
|
2019
Q3 | $3.21M | Sell |
295,761
-2,574
| -0.9% | -$28K | ﹤0.01% | 2500 |
|
|
2019
Q2 | $2.79M | Buy |
298,335
+12,275
| +4% | +$124K | ﹤0.01% | 2627 |
|
|
2019
Q1 | $3.51M | Sell |
286,060
-3,845
| -1% | -$46.9K | ﹤0.01% | 2503 |
|
|
2018
Q4 | $3.43M | Sell |
289,905
-28,211
| -9% | -$387K | ﹤0.01% | 2482 |
|
|
2018
Q3 | $4.58M | Sell |
318,116
-8,416
| -3% | -$116K | ﹤0.01% | 2445 |
|
|
2018
Q2 | $4.87M | Sell |
326,532
-478
| -0.1% | -$6.64K | ﹤0.01% | 2404 |
|
|
2018
Q1 | $4.27M | Buy |
327,010
+2,405
| +0.7% | +$31.6K | ﹤0.01% | 2434 |
|
|
2017
Q4 | $4.09M | Buy |
324,605
+3,730
| +1% | +$47.1K | ﹤0.01% | 2451 |
|
|
2017
Q3 | $4.16M | Buy |
320,875
+111,296
| +53% | +$1.47M | ﹤0.01% | 2427 |
|
|
2017
Q2 | $3.11M | Buy |
209,579
+37,603
| +22% | +$523K | ﹤0.01% | 2575 |
|
|
2017
Q1 | $2.06M | Sell |
171,976
-2,730
| -2% | -$34.6K | ﹤0.01% | 2834 |
|
|
2016
Q4 | $2.41M | Buy |
174,706
+15,303
| +10% | +$212K | ﹤0.01% | 2739 |
|
|
2016
Q3 | $2.14M | Sell |
159,403
-284
| -0.2% | -$3.44K | ﹤0.01% | 2723 |
|
|
2016
Q2 | $1.72M | Sell |
159,687
-1,214
| -0.8% | -$13.4K | ﹤0.01% | 2805 |
|
|
2016
Q1 | $1.69M | Buy |
160,901
+2,790
| +2% | +$30.6K | ﹤0.01% | 2747 |
|
|
2015
Q4 | $1.87M | Sell |
158,111
-3,476
| -2% | -$42.7K | ﹤0.01% | 2751 |
|
|
2015
Q3 | $1.89M | Sell |
161,587
-29,105
| -15% | -$386K | ﹤0.01% | 2779 |
|
|
2015
Q2 | $2.75M | Buy |
190,692
+1,541
| +0.8% | +$22.2K | ﹤0.01% | 2710 |
|
|
2015
Q1 | $2.64M | Sell |
189,151
-5,652
| -3% | -$78.1K | ﹤0.01% | 2673 |
|
|
2014
Q4 | $2.69M | Buy |
194,803
+1,054
| +0.5% | +$13.6K | ﹤0.01% | 2658 |
|
|
2014
Q3 | $2.37M | Sell |
193,749
-1,212
| -0.6% | -$15.1K | ﹤0.01% | 2755 |
|
|
2014
Q2 | $2.44M | Sell |
194,961
-5,207
| -3% | -$61.3K | ﹤0.01% | 2786 |
|
|
2014
Q1 | $2.23M | Sell |
200,168
-7,371
| -4% | -$80.9K | ﹤0.01% | 2808 |
|
|
2013
Q4 | $2.52M | Buy |
207,539
+10,487
| +5% | +$125K | ﹤0.01% | 2746 |
|
|
2013
Q3 | $2.4M | Sell |
197,052
-44,391
| -18% | -$619K | ﹤0.01% | 2726 |
|
|
2013
Q2 | $3.19M | Buy |
+241,443
| New | +$3.34M | ﹤0.01% | 2467 |
|
Other funds holding LFCR
DA
TAM
GCP
CA
DT
N
Bank of New York Mellon's LFCR Position: Q2 2026 in Review
Bank of New York Mellon increased its Lifecore Biomedical (LFCR) stake by 15% in Q2 2026, buying an estimated $44.4K and bringing the position to 67,272 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #3924.
Bank of New York Mellon first reported a position in LFCR in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.87M in Q2 2018. 36 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.
- Bank of New York Mellon held 67,272 shares of Lifecore Biomedical worth $353K as of Q2 2026.
- Bank of New York Mellon bought 8,806 Lifecore Biomedical shares in Q2 2026, an estimated $44.4K.
- Lifecore Biomedical made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3924 holding.
- Bank of New York Mellon first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 52 quarters since.
- Bank of New York Mellon's Lifecore Biomedical position peaked at $4.87M in Q2 2018.
- 36 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.